IL-12 inhibitors (DiaKine)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameIL-12 inhibitors (DiaKine)
Drug Alias NameIL-12 modulators (DiaKine/University of Virginia)CT-12441DT-22669DT-23552
ClassificationSmall molecules
Mechanisms of ActionImmunosuppressantsInterleukin-12 receptor inhibitors
TargetsInterleukin-12 receptor
Therapy Area/IndicationsDiabetes MellitusDiabetic NephropathiesDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Virginia
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDiakine Therapeutics IncUniversity Of Virginia
Active IndicationsN/A
Inactive IndicationsDiabetes MellitusDiabetic NephropathiesDiabetic Retinopathy

Other Information

ATC CodeN/A
Related LinksN/A